PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
STRGX vs. BME
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between STRGX and BME is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

STRGX vs. BME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sterling Capital Stratton Mid Cap Value Fund (STRGX) and BlackRock Health Sciences Trust (BME). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-6.28%
-0.72%
STRGX
BME

Key characteristics

Sharpe Ratio

STRGX:

0.14

BME:

-0.01

Sortino Ratio

STRGX:

0.29

BME:

0.07

Omega Ratio

STRGX:

1.05

BME:

1.01

Calmar Ratio

STRGX:

0.09

BME:

-0.01

Martin Ratio

STRGX:

0.42

BME:

-0.03

Ulcer Index

STRGX:

6.39%

BME:

4.26%

Daily Std Dev

STRGX:

18.42%

BME:

11.96%

Max Drawdown

STRGX:

-57.68%

BME:

-42.03%

Current Drawdown

STRGX:

-27.17%

BME:

-4.36%

Returns By Period

In the year-to-date period, STRGX achieves a 4.05% return, which is significantly lower than BME's 4.74% return. Over the past 10 years, STRGX has underperformed BME with an annualized return of 1.53%, while BME has yielded a comparatively higher 7.51% annualized return.


STRGX

YTD

4.05%

1M

4.49%

6M

-6.28%

1Y

1.96%

5Y*

-1.71%

10Y*

1.53%

BME

YTD

4.74%

1M

7.60%

6M

-0.72%

1Y

0.32%

5Y*

4.71%

10Y*

7.51%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

STRGX vs. BME — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

STRGX
The Risk-Adjusted Performance Rank of STRGX is 88
Overall Rank
The Sharpe Ratio Rank of STRGX is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of STRGX is 88
Sortino Ratio Rank
The Omega Ratio Rank of STRGX is 99
Omega Ratio Rank
The Calmar Ratio Rank of STRGX is 88
Calmar Ratio Rank
The Martin Ratio Rank of STRGX is 88
Martin Ratio Rank

BME
The Risk-Adjusted Performance Rank of BME is 4040
Overall Rank
The Sharpe Ratio Rank of BME is 4444
Sharpe Ratio Rank
The Sortino Ratio Rank of BME is 3434
Sortino Ratio Rank
The Omega Ratio Rank of BME is 3434
Omega Ratio Rank
The Calmar Ratio Rank of BME is 4444
Calmar Ratio Rank
The Martin Ratio Rank of BME is 4444
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

STRGX vs. BME - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sterling Capital Stratton Mid Cap Value Fund (STRGX) and BlackRock Health Sciences Trust (BME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for STRGX, currently valued at 0.14, compared to the broader market-1.000.001.002.003.004.000.14-0.01
The chart of Sortino ratio for STRGX, currently valued at 0.29, compared to the broader market0.005.0010.000.290.07
The chart of Omega ratio for STRGX, currently valued at 1.05, compared to the broader market1.002.003.004.001.051.01
The chart of Calmar ratio for STRGX, currently valued at 0.09, compared to the broader market0.005.0010.0015.0020.000.09-0.01
The chart of Martin ratio for STRGX, currently valued at 0.42, compared to the broader market0.0020.0040.0060.0080.000.42-0.03
STRGX
BME

The current STRGX Sharpe Ratio is 0.14, which is higher than the BME Sharpe Ratio of -0.01. The chart below compares the historical Sharpe Ratios of STRGX and BME, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2025
0.14
-0.01
STRGX
BME

Dividends

STRGX vs. BME - Dividend Comparison

STRGX's dividend yield for the trailing twelve months is around 0.70%, less than BME's 6.73% yield.


TTM20242023202220212020201920182017201620152014
STRGX
Sterling Capital Stratton Mid Cap Value Fund
0.70%0.72%0.82%0.93%0.61%0.50%0.90%0.54%0.44%0.14%0.29%0.04%
BME
BlackRock Health Sciences Trust
6.73%6.87%6.32%5.87%5.03%5.04%5.65%6.58%6.58%9.45%17.04%9.83%

Drawdowns

STRGX vs. BME - Drawdown Comparison

The maximum STRGX drawdown since its inception was -57.68%, which is greater than BME's maximum drawdown of -42.03%. Use the drawdown chart below to compare losses from any high point for STRGX and BME. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-27.17%
-4.36%
STRGX
BME

Volatility

STRGX vs. BME - Volatility Comparison

Sterling Capital Stratton Mid Cap Value Fund (STRGX) has a higher volatility of 5.05% compared to BlackRock Health Sciences Trust (BME) at 4.70%. This indicates that STRGX's price experiences larger fluctuations and is considered to be riskier than BME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%AugustSeptemberOctoberNovemberDecember2025
5.05%
4.70%
STRGX
BME
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab